Regulatory T cells in ischemic cardiovascular injury and repair

J Mol Cell Cardiol. 2020 Oct:147:1-11. doi: 10.1016/j.yjmcc.2020.08.004. Epub 2020 Aug 7.

Abstract

Ischemic injury triggers a heightened inflammatory response that is essential for tissue repair, but excessive and chronic inflammatory responses contribute to the pathogenesis of ischemic cardiovascular disease. Regulatory T cells (Tregs), a major regulator of self-tolerance and immune suppression, control innate and adaptive immune responses, modulate specific immune cell subsets, prevent excessive inflammation, and participate in tissue repair after ischemia. Herein, we summarize the multiple potential mechanisms by which Tregs exert suppressor functions including modulation of cytokine production, alteration of cell-cell interactions, and disruption of metabolic pathways. Furthermore, we review the role of Tregs implicated in ischemic injury and repair including myocardial, limb, and cerebral ischemia. We conclude with a perspective on the therapeutic opportunities and future challenges of Treg biology in understanding the pathogenesis of ischemic cardiovascular disease states.

Keywords: Cerebral ischemic injury; Ischemic injury; Limb ischemic injury; Myocardial ischemic injury; Regulatory T cells; Tissue repair.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Models, Biological
  • Myocardial Ischemia / immunology*
  • Myocardial Ischemia / pathology*
  • Myocardial Ischemia / therapy
  • T-Lymphocytes, Regulatory / immunology*
  • Wound Healing*